4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
7.28
0.18 (2.54%)
At close: Aug 15, 2025, 3:59 PM
7.22
-0.76%
After-hours: Aug 15, 2025, 04:10 PM EDT
2.54% (1D)
| Bid | 7.2 |
| Market Cap | 339.74M |
| Revenue (ttm) | 23K |
| Net Income (ttm) | -176.44M |
| EPS (ttm) | -3.53 |
| PE Ratio (ttm) | -2.06 |
| Forward PE | -1.47 |
| Analyst | Buy |
| Ask | 7.7 |
| Volume | 1,037,479 |
| Avg. Volume (20D) | 1,071,130 |
| Open | 7.23 |
| Previous Close | 7.10 |
| Day's Range | 7.01 - 7.53 |
| 52-Week Range | 2.23 - 17.41 |
| Beta | 2.82 |
About FDMT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FDMT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FDMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
4D Molecular Therapeutics has released their quartely earnings
on Aug 11, 2025:
Next Earnings Release
4D Molecular Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+42.67%
4D Molecular Therapeutics shares are trading highe...
Unlock content with
Pro Subscription
2 weeks ago
+2.04%
4D Molecular Therapeutics shares are trading higher after the company announced results from its 4D-150 SPECTRA clinical trial.
